(Press-News.org) A new development in engineering chimeric antigen receptor (CAR) T cells, called affinity tuning, can make the CAR T cells spare normal cells and better recognize and attack cancer cells, which may help lower the toxicity associated with this type of immunotherapy when used against solid tumors, according to a preclinical study.
Many solid cancers have high levels of certain proteins such as ErbB2 and EGFR, which make them suitable targets for anticancer therapies. However, such proteins are also present at low levels in normal cells. Because of this, CAR T cells that are developed to target one of these proteins on tumor cells also recognize and attack normal cells that have the protein, causing severe toxicity. Zhao and colleagues are working to address this challenge.
To develop CAR T cells that can distinguish between cancer and normal cells, Zhao and colleagues first constructed a panel of CARs with the scFvs using sequences from mutated 4D5 antibodies that had varying affinities to ErbB2, a protein present at high levels in some solid tumors, including breast cancer. Next, they incorporated different scFvs into the CAR backbone or "construct," such that they resulted in a range of CAR T cells--from those that had high affinity to ErbB2 to those that had low affinity to ErbB2. The newly engineered CAR T cells varied in their affinity to ErbB2 by three orders of magnitude.
The researchers then conducted a series of experiments to test the functionality of the affinity-tuned CAR T cells and found that high-affinity CAR T cells did not discriminate tumor cells from normal cells and attacked all of them, whereas low-affinity CAR T cells were sensitive to tumor cells that had high levels of ErbB2 and not to normal cells that had low levels of the protein.
Next, they tested the engineered CAR T cells in mice that bore human cells with high levels of ErbB2 on one side of their bodies and human cells with normal levels of ErbB2 on the other side of their bodies. Here again, low-affinity CAR T cells selectively eliminated cells that had high levels of ErbB2 but had no effect on cells that had normal levels of the protein.
In order to prove that this technology can be extended to other solid tumor targets, the researchers developed low-affinity CAR T cells targeting EGFR, a protein present in high levels in some lung and colon cancers, among others, and preliminary preclinical results showed that these CAR T cells were able to discriminate between cancer cells and normal cells.
In an interview, Zhao said, "CAR T-cell therapies are very promising for leukemias, with high response rates, but adapting this treatment approach to solid tumors has been a great challenge. One of the reasons for this is the lack of good targets.
"I and my colleagues at the laboratory of Carl June, MD, director of the University of Pennsylvania's Center for Cellular Immunotherapies, have been working for the past three years to optimize a system to fine-tune the affinity of single chain variable fragments (scFv)--the part of the CAR T cell that recognizes the tumor target--such that they are able to discriminate tumors that have high levels of a protein from normal tissues that have low levels of the same protein," Zhao explained.
"Unlike the common expectation that lowering the affinity of CAR T cells might also lower their efficacy, we have shown that lowering the affinity in fact does the opposite--lower-affinity CAR T cells displayed more potent reactivity to tumor cells expressing high levels of the target than did higher-affinity CAR T cells," Zhao said.
INFORMATION:
Journal in Which the Study was Published: Cancer Research, a journal of the American Association for Cancer Research
Author: Yangbing Zhao, MD, PhD, director of the T-Cell Engineering Laboratory (TCEL) at the Center for Cellular Immunotherapies and an adjunct associate professor in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania
Funding & Disclosures: This study was funded by the National Institutes of Health and Novartis. June and Zhao have financial interests due to intellectual property and patents in the field of cell and gene therapy. Conflicts of interest are managed in accordance with University of Pennsylvania policy and oversight.
For further reading:
CAR T-cell Therapy: Engineering Patients' Immune Cells to Treat Their Cancers
Follow us: Cancer Research Catalyst http://blog.aacr.org; Twitter @AACR; and Facebook http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in 101 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 25 conferences and educational workshops, the largest of which is the AACR Annual Meeting with almost 19,300 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org.
To interview Yangbing Zhao, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896.
Engineering chimeric antigen receptor (CAR) T cells to lower their affinity for the protein epithelial growth factor receptor (EGFR) made the cells preferentially recognize and eliminate tumor cells that have high amounts of EGFR while sparing normal cells that have lower amounts of the protein, according to a preclinical study.
CAR T cells that are currently being tested to treat B-cell malignancies target a specific protein present on leukemia and lymphoma, but these immune cells cannot distinguish cancer cells from normal cells, explained Cooper. Even though such ...
In recent years, an effort has been underway to redefine malnutrition in pediatric patients to include both the acute clinical population and the more traditional ambulatory populations. Identifying and treating malnutrition in pediatric patients is important from an acute standpoint and to ensure that children have enough nutrition to reach optimal final height and development.
Pediatric malnutrition in the clinical setting was recently defined by the Academy of Nutrition and Dietetics and A.S.P.E.N. as "an imbalance between nutrient requirements and intake that results ...
ANN ARBOR--Daily marijuana use among the nation's college students is on the rise, surpassing daily cigarette smoking for the first time in 2014.
A series of national surveys of U.S. college students, as part of the University of Michigan's Monitoring the Future study, shows that marijuana use has been growing slowly on the nation's campuses since 2006.
Daily or near-daily marijuana use was reported by 5.9 percent of college students in 2014--the highest rate since 1980, the first year that complete college data were available in the study. This rate of use is up ...
The fossil of a previously unknown species of 'sea scorpion', measuring over 1.5 meters long, has been discovered in Iowa, USA, and described in the open access journal BMC Evolutionary Biology.
Dating back 460 million years, it is the oldest known species of eurypterid (sea scorpion) - extinct monster-like predators that swam the seas in ancient times and are related to modern arachnids.
The authors named the new species Pentecopterus decorahensis after the 'penteconter' - an ancient Greek warship that the species resembles in outline and parallels in its predatory ...
Many of the most memorable stories in the history of science revolve around the conscious realization of an idea - the "Eureka!" moment. But what triggers these moments? Is there always some serendipitous event preceding a sudden epiphany, such as when Isaac Newton famously figured out gravity when he saw a falling apple?
Writing in September's Physics World, Vitor Cardoso talks about how these questions led him on a quest of discovery through the web-based project The Birth of an Idea, which he co-founded with artist Ana Souse Carvalho.
"Ana and I had been talking ...
Women living in poor areas in the UK are almost twice as likely to develop clinical anxiety as women in richer areas. However, whether men lived in poorer or richer areas made no difference to their levels of generalised anxiety disorder (GAD). These are amongst the main findings of a major survey on how socio-economic factors affect mental health in the UK.
Generalised anxiety disorder is one of the most common mental health conditions in modern society, but little objective work has taken place to show the factors in society which can lead to the development of anxiety. ...
How do you convince someone with schizophrenia or other psychotic disorders that they are ill if they don't want to believe it? If you don't recognize that you are ill, you may resist treatment, but is there something which causes this lack of awareness? Awareness of illness, also known as 'insight', is a serious problem in the treatment of psychotic patients. Now work being presented at the ECNP Congress in Amsterdam investigates whether concentrations of a marker of brain cell dysfunction are associated with impaired insight.
Past studies have indicated that an area ...
Men with relatively unaggressive prostate tumors and whose disease is carefully monitored by urologists are unlikely to develop metastatic prostate cancer or die of their cancers, according to results of a study by researchers at the Brady Urological Institute at Johns Hopkins, who analyzed survival statistics up to 15 years.
Specifically, the researchers report, just two of 1,298 men enrolled over the past 20 years in a so-called active surveillance program at Johns Hopkins died of prostate cancer, and three developed metastatic disease.
"Our study should reassure ...
Lincoln, Neb., Aug. 31, 2015 -- Using an enormous X-ray laser -- one of only two such machines on Earth -- University of Nebraska-Lincoln physicist Matthias Fuchs and scientists from around the world beat formidable odds to observe one of the most fundamental interactions between X-rays and matter.
The findings can aid future studies and may lead to novel new ways to diagnose matter in the future.
Fuchs and his colleagues induced two X-ray photons to simultaneously collide with a single atom, which converts them into a single higher-energetic X-ray photon. It's a phenomenon ...
New York, NY--August 31, 2015--With the rise of CO2 in Earth's atmosphere, understanding the climate of tropical forests--the Amazon in particular--has become a critical research area. A recent NASA study showed that these regions are the biggest terrestrial carbon dioxide sinks on our planet, absorbing 1.4 billion metric tons of CO2 out of a total global terrestrial absorption of 2.5 billion. To simulate the tropical climate to learn more about its processes, climate scientists have typically been relying on general circulation models (GCMs) to simulate the tropical climate. ...
